📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
29 announcements match the current filters (relevance ≥ 5).
Deepak Nitrite Infuses ₹135 Cr into Subsidiary Deepak Chem Tech for Project Expansion
Deepak Nitrite (DNL) and its subsidiary Deepak Phenolics (DPL) have collectively invested ₹135 Crores into Deepak Chem Tech Limited (DCTL). The investment was made through the allotment of 1.35 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at ₹100 each. These funds are intended to strengthen DCTL's capital base and support its ongoing projects in Fluorination, Nitric Acid, and Nitration. DCTL is a growing subsidiary, with its turnover increasing from ₹0.86 Crores in FY24 to ₹9.43 Crores in FY25.
Key Highlights
Total capital infusion of ₹135 Crores into wholly-owned subsidiary Deepak Chem Tech Limited.
Issuance of 1.10 crore OCRPS to Deepak Phenolics and 25 lakh OCRPS to Deepak Nitrite at ₹100 par value.
Funds will support project expenses for Fluorination, Nitric Acid, Nitration, and Hydrogenation plants.
DCTL's turnover showed significant growth, reaching ₹9.43 Crores in FY 2024-25.
The 9% OCRPS are designed to provide flexible capital structure for the subsidiary's expansion in Gujarat.
👀 What to Watch
Investors should monitor the commissioning of DCTL's specialized chemical plants as they represent a key growth vertical for the group. The internal funding demonstrates the parent company's strong cash position and commitment to high-margin chemical segments.
Deepak Nitrite Subsidiary DPL Invests ₹100 Crore in Deepak Chem Tech via OCRPS
Deepak Nitrite's wholly-owned subsidiary, Deepak Phenolics Limited (DPL), has invested ₹100 Crores into another subsidiary, Deepak Chem Tech Limited (DCTL). The investment was executed through the allotment of 1 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at par value. This capital infusion is designed to strengthen DCTL's capital base and fund ongoing project expenses. DCTL is currently scaling its fluorination plant operations and pursuing multiple projects across Gujarat.
Key Highlights
Deepak Phenolics Limited invested ₹100 Crores in Deepak Chem Tech Limited via 9% OCRPS.
DCTL's turnover increased significantly from ₹0.86 Crores in FY24 to ₹9.43 Crores in FY25.
The funds are earmarked for project expenses and general corporate purposes within the fluorination segment.
Deepak Nitrite continues to maintain 100% indirect control over DCTL's preference share capital.
DCTL operates a state-of-the-art fluorination plant and is expanding its footprint in Gujarat.
👀 What to Watch
This is an internal capital reallocation to support the high-growth fluorination business; investors should track DCTL's project execution as it scales from a low revenue base. No immediate impact on consolidated financials is expected, but it signals long-term expansion in specialized chemicals.
Deepak Nitrite Q3 FY26: EBITDA Grows 16% to ₹219 Cr Amid Volume-Led Growth
Deepak Nitrite reported a steady Q3 FY26 with consolidated revenue rising 3% YoY to ₹1,983 crore, driven by higher volumes despite global pricing pressures. EBITDA increased 16% YoY to ₹219 crore, with margins improving to 11% due to operational efficiencies and vertical integration. While the Phenolics segment saw a 20% YoY EBIT growth, the Advanced Intermediates segment faced margin compression from aggressive Chinese competition. The company is nearing the commissioning of its MIBK/MIBC project and is progressing on its transformational polycarbonate plant.
Key Highlights
Consolidated Q3 revenue reached ₹1,983 crore, up 3% YoY, with EBITDA rising 16% to ₹219 crore.
Phenolics segment EBIT grew 20% YoY to ₹145 crore, while Advanced Intermediates revenue rose 18% to ₹652 crore.
Commissioned new nitric acid and nitration plants, completing vertical integration for the ammonia-to-amines value chain.
MIBK/MIBC project targeted for commissioning in Q4 FY26; Polycarbonate project funding is in final stages.
Maintained a strong balance sheet with a net worth of ₹5,651 crore and a consolidated ROCE of 15%.
👀 What to Watch
Investors should focus on the successful ramp-up of newly commissioned capacities and the upcoming MIBK/MIBC project which are expected to improve margins. The company's strategy of vertical integration and import substitution makes it a resilient long-term play in the specialty chemicals space.
Deepak Nitrite Q3 FY26: EBITDA Grows 16% YoY to ₹219 Cr; US Removes 45% Sodium Nitrite Duty
Deepak Nitrite reported a resilient Q3 FY26 with consolidated revenue of ₹1,983 crore, a 3% YoY increase, and EBITDA growth of 16% YoY to ₹219 crore. The Phenolics segment drove profitability with a 20% YoY EBIT increase to ₹145 crore, while Advanced Intermediates faced pricing pressure from Chinese dumping despite 18% revenue growth. A significant regulatory tailwind emerged as the US removed a 45.16% Anti-Dumping Duty on the company's Sodium Nitrite exports. The company is also advancing its 165,000 MT Polycarbonate project and expects MIBK/MIBC commissioning in Q4 FY26.
Key Highlights
Q3 FY26 Revenue rose 3% YoY to ₹1,983 crore, while EBITDA increased 16% YoY to ₹219 crore.
US Department of Commerce removed 45.16% Anti-Dumping Duty on Sodium Nitrite exports effective January 2026.
Phenolics segment EBIT grew 20% YoY to ₹145 crore supported by higher volumes and operating efficiencies.
Completed vertical integration across the ammonia-nitration-amines chain with new Nitric Acid plant commissioning.
MIBK/MIBC project targeted for Q4 FY26 commissioning; Polycarbonate plant relocation from Germany is on schedule.
👀 What to Watch
Investors should focus on the margin expansion potential from the newly commissioned backward integration plants and the removal of US export duties. While Chinese competition remains a headwind, the company's shift toward high-value specialty materials like Polycarbonate offers long-term growth prospects.
Deepak Nitrite Q3 Results: Consolidated PAT flat at ₹100 Cr; Revenue up 4% YoY
Deepak Nitrite reported a marginal 3.7% YoY growth in consolidated revenue to ₹1,975 Cr for Q3 FY26, while consolidated net profit remained nearly flat at ₹100 Cr. The standalone business saw strong revenue growth of 25.7% YoY but suffered a significant profit decline due to an exceptional provision of ₹10.51 Cr for new labor codes and higher material costs. The Phenolics segment, a major contributor, saw a slight revenue dip but maintained steady segment results. Overall 9-month performance remains under pressure with a 33% decline in consolidated net profit compared to the previous year.
Key Highlights
Consolidated Revenue from operations grew 3.7% YoY to ₹1,974.97 Cr from ₹1,903.40 Cr.
Consolidated Net Profit stood at ₹99.82 Cr, up marginally from ₹98.13 Cr in the same quarter last year.
Exceptional item of ₹12.84 Cr (Consolidated) recognized due to the implementation of New Labour Codes.
Advanced Intermediates segment revenue increased to ₹652.45 Cr from ₹551.69 Cr YoY.
9-month consolidated PAT fell to ₹330.83 Cr from ₹494.85 Cr in the prior year period.
👀 What to Watch
The results show a stabilization in quarterly performance, but long-term growth remains muted compared to last year. Investors should monitor the recovery in the Phenolics segment and the impact of raw material price volatility on margins.
Deepak Nitrite Q3 FY26 Consolidated Net Profit Rises 21% YoY to ₹118.75 Crore
Deepak Nitrite reported a steady performance for Q3 FY26, with consolidated revenue growing 3.8% YoY to ₹1,974.97 crore. Consolidated net profit increased significantly by 21% YoY to ₹118.75 crore, despite an exceptional charge of ₹12.84 crore related to the New Labour Codes. The Phenolics segment remains the primary driver, contributing ₹1,333.79 crore to revenue and ₹145.32 crore to segment results. Advanced Intermediates showed revenue growth but lower margins compared to the previous quarter.
Key Highlights
Consolidated Net Profit grew 21% YoY to ₹118.75 Cr, overcoming an exceptional cost of ₹12.84 Cr.
Total Consolidated Revenue reached ₹1,974.97 Cr, up from ₹1,903.40 Cr in the same quarter last year.
Phenolics segment EBIT stood strong at ₹145.32 Cr on revenue of ₹1,333.79 Cr.
Advanced Intermediates segment revenue grew to ₹652.45 Cr, though segment results dipped to ₹14.94 Cr.
Company recognized an exceptional item of ₹12.84 Cr due to the implementation of New Labour Codes.
👀 What to Watch
Investors should monitor the sustained performance of the Phenolics division and the margin recovery in Advanced Intermediates. The stock remains a solid play in the specialty chemicals space given the healthy year-on-year profit growth.
Deepak Nitrite Subsidiary DPL Invests ₹80 Crore in Deepak Chem Tech via Preference Shares
Deepak Phenolics Limited (DPL), a wholly owned subsidiary of Deepak Nitrite, has invested ₹80 Crores into another subsidiary, Deepak Chem Tech Limited (DCTL). The investment was executed through the allotment of 80,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at ₹100 each. This internal capital infusion is designed to strengthen DCTL's capital base and fund its ongoing project expenses, particularly for its Fluorination plant. DCTL is showing early growth signs, with turnover rising from ₹0.86 Crores in FY24 to ₹9.43 Crores in FY25.
Key Highlights
Allotment of 80,00,000 9% OCRPS at par, aggregating to ₹80 Crores
DCTL turnover grew significantly to ₹9.43 Crores in FY 2024-25 from ₹0.86 Crores in FY 2023-24
Funds earmarked for DCTL's state-of-the-art Fluorination plant and other Gujarat-based projects
Deepak Nitrite maintains 100% control over both subsidiaries involved in the transaction
DCTL's total paid-up capital prior to this allotment stood at ₹1,919.50 Crores
👀 What to Watch
This is an internal capital reallocation to support the company's expansion into specialized chemical segments like Fluorination. Investors should view this as a commitment to long-term growth in high-margin verticals, though it has no immediate impact on consolidated financials.
Deepak Nitrite Subsidiary Commissions Nitration & Hydrogenation Plant for ₹85 Crores
Deepak Nitrite's wholly-owned subsidiary, Deepak Chem Tech Limited, has successfully commissioned its Nitration and 2nd Hydrogenation Plant at Dahej, Gujarat. The project involved a total capital expenditure of approximately ₹85 Crores as of the commissioning date on January 19, 2026. This expansion is expected to enhance the company's chemical processing capabilities and downstream integration. The timely commissioning of this facility reflects the company's focus on scaling its specialty chemicals portfolio.
Key Highlights
Commissioning of Nitration and 2nd Hydrogenation Plant at Dahej, Dist. Bharuch, Gujarat.
Total capital expenditure incurred for the project is approximately ₹85 Crores.
The facility is operated by Deepak Chem Tech Limited, a material wholly-owned subsidiary.
The plant was officially commissioned on January 19, 2026.
👀 What to Watch
Investors should view this as a positive step towards capacity expansion and monitor the subsequent impact on revenue growth in the specialty chemicals segment. No immediate action is required, but the development strengthens the long-term growth thesis.
Deepak Nitrite Subsidiary Starts Nitric Acid Plant Operations; ₹515 Cr Capex Incurred
Deepak Chem Tech Limited, a wholly owned subsidiary of Deepak Nitrite, has commenced manufacturing operations at its Nitric Acid Plant in Nandesari, Gujarat, as of December 4, 2025. The project involved a total capital expenditure of approximately ₹515 Crores. This strategic move strengthens the group's backward and forward integration, enhancing supply security for key intermediates. The facility allows the group to evolve into a more integrated chemical platform, spanning from Ammonia to Amines.
Key Highlights
Commencement of Nitric Acid Plant operations at Nandesari, Gujarat, on December 4, 2025.
Total capital expenditure for the project is approximately ₹515 Crores.
Strengthens backward and forward integration, reinforcing supply security for key intermediates.
Enables deeper penetration into high-value applications and enhances resilience.
Positions the group as an integrated platform from Ammonia to Amines, a capability held by few global players.
👀 What to Watch
Investors should view this as a positive development for long-term margin expansion and supply chain stability. Monitor the plant's ramp-up and its contribution to the company's specialty chemical segment in upcoming quarters.
